WESTPORT, Jul 10 (Reuters) - The results of two new
studies published in the July 11th issue of The
Lancet call into question the efficacy of tamoxifen in the prevention
of breast cancer. Dr. U. Veronesi of the European Institute of Oncology
in Milan, and colleagues there and elsewhere in Italy report
preliminary findings from the Italian Tamoxifen Prevention Study showing
that breast cancer rates are not reduced.
HOpe this information benefits
God Bless
marty auslander
------------------------------------------------------------------------
This is an automatically-generated notice. If you'd like to be removed
from the mailing list, please visit the Medicine-On-Line Discussion Forum
at <http://www.meds.com/con_faq.html>, or send an email message to:
majordomo@lists.meds.com
with the subject line blank and the body of the message containing the line:
unsubscribe mol-cancer your-email-address
where the phrase your-email-address is replaced with your actual email
address.
------------------------------------------------------------------------
